Dry powder formulations of nucleic acid lipid nanoparticles

Abstract

In some aspects, the present disclosure provides dry powder pharmaceutical compositions comprising: (A) a nucleic acid; (B) a lipid nanoparticle; wherein the nucleic acid is substantially encapsulated in the lipid nanoparticle; (C) a sugar; and (D) a pharmaceutically acceptable polymer. The dry …